At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 60 enrolled
Drug / intervention
Chungkookjang +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Chungkookjang, a Fermented Soy Paste, on Histamine-induced Wheal Size
In Brief
A Phase 3 clinical trial evaluating Chungkookjang and Placebo for Healthy Subjects. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The investigators investigate the effect of Chungkookjang on histamine-induced skin reaction in a double-blind, randomized, placebo-controlled, human trial
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Subjects
CountriesSouth Korea
Collaborators--
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2010
Primary CompletionJul 2011
First PostedJul 2011
Study CompletionSep 2011
TodayJul 2026
First PostedJul 26, 2011
Enrollment StartOct 1, 2010
Primary CompletionJul 1, 2011
Study CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.9 years ago
Interventions
Chungkookjangdietary
Chungkookjang(35g/say)for 12 weeks
Placebodietary
Placebo(35g/day) for 12 weeks